Physician

Daniel G Fagel, M.D.

According to 2025 Medicare claims, Daniel Fagel, M.D. (NPI: 1518964147) practices gastroenterology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is TRI-STATE GASTROENTEROLOGY ASSOCIATES, PSC (NPI: 1306843842; TIN: 611192347) and primary practice location at 41017-3409. Fagel is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Fagel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 514 traditional Medicare patients, billed 10,368 HCPCS/CPT codes, and received $193,754 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 3,156 prescription claims across 854 beneficiaries totaling $977,726 in drug costs, led by Sucraid (Sacrosidase). 2019 DME data shows 165 claims. Open Payments data shows 125 records totaling $2,177. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,253,869 to $977,726. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	565	2,015	$137,118
2016	577	1,539	$111,039
2017	583	1,344	$111,247
2018	601	14,131	$126,915
2019	555	3,467	$107,966
2020	463	994	$86,021
2021	521	10,789	$121,430
2022	522	1,691	$112,091
2023	586	9,527	$152,258
2024	514	10,368	$193,754

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	424	2,460	$1,253,869
2016	448	2,458	$774,189
2017	504	2,492	$1,166,522
2018	521	2,496	$635,977
2019	527	2,387	$645,003
2020	585	2,454	$735,244
2021	620	2,524	$602,581
2022	655	2,517	$652,708
2023	742	2,810	$814,892
2024	854	3,156	$977,726

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	151	$69,933
2019	N/R	165	$90,722
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	187	187	$194
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	187	233	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	120	128	$64
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	140	143	$63
43450	Dilation of esophagus	96	101	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Sucraid	Sacrosidase	16	480	$222,029
Linzess	Linaclotide	110	7,470	$131,331
Creon	Lipase/Protease/Amylase	21	761	$49,660
Dexlansoprazole Dr	Dexlansoprazole	48	3,720	$22,515
Trulance	Plecanatide	14	1,260	$21,986

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	125	$2,177	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel G. Fagel, M.D.?

Tedicare shows public-source Medicare data for Daniel G. Fagel, M.D. (NPI 1518964147), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel G. Fagel, M.D. have ACO affiliation data?

Daniel G. Fagel, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Daniel G. Fagel, M.D.?

Daniel G. Fagel, M.D. is linked to TRI-STATE GASTROENTEROLOGY ASSOCIATES, PSC (billing NPI 1306843842) in the available physician profile data.

Does Daniel G. Fagel, M.D. have Open Payments data?

Daniel G. Fagel, M.D. has 125 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.